BNTC
$0.25
Benitec Biopharma Ltd ADR
$.00
(.40%)
BNTC
Earnings Whisper ®
N/A
Consensus: $0.00
Revenue: N/A
Share
Watch
What do you expect when BNTC reports earnings?
Where is BNTC's stock price going from here?
Analysts
Description
Benitec Biopharma Limited is a biotechnology company which developed a patented gene silencing technology delivered by gene therapy called DNA directed RNA interference. The company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including hepatitis C and B, drug resistant lung cancer and wet age-related macular degeneration. Benitec Biopharma Limited is based in Sydney, Australia.